A judge has placed a licensing deal between Immunomedics Inc. (Nasdaq: IMMU) and Seattle Genetics Inc. (Nasdaq: SGEN) on hold due to an investor lawsuit. Shares of Immunomedics climbed 98 cents to close at $6.01 while Seattle Genetics stock lost 33 cents to close at $67.10.
Immunomedics - Seattle Genetics licensing deal on hold
March 09, 2017 at 17:58 PM EST
